Advocacy

Advocacy Coping With Cancer

Passing of The Baton—On the Death of Patient Research Advocates

*January 2023* By Angus Pratt When I was diagnosed with lung cancer in 2018, there was a small community of patient research advocates—or PRAs. We were a small community because most of us did not live long enough to get involved in advocacy. Fortunately, now we are surviving longer, which…

laurabbook@gmail.comFebruary 3, 2023

Advocacy Funding Research

Video Summary Recap: 2022 EGFR Resisters Research Summit

*December 2022* The EGFR Resisters held our 4th Annual 2022 EGFR Resisters Research Summit on November 17-18, 2022 in Chicago. Please watch this video to learn more about the summit and the lung cancer research presented by the Young Investigators who participated.

laurabbook@gmail.comDecember 19, 2022

Advocacy Funding

Lung Cancer Research Foundation (LCRF) and EGFR Resisters Announce Research Awards

*December 2022* The EGFR Resisters are thrilled to announce the THREE 2022 grant recipients of our research award partnership with Lung Cancer Research Foundation. Each project will receive $150,000 for 2 years, for a total of $450,000 of funding. Please read the press release here for more details about the…

laurabbook@gmail.comDecember 19, 2022

Advocacy Research

Epidemiology of Young Lung Cancer Study

*October 2022* Given all the exciting news out of ESMO about mechanisms of air pollution coupled with EGFR mutation, the GO2 Foundation for Lung Cancer and ALCMI want to re-flag this study! They are hoping to be able to do an interim analysis in time for ASCO 2023 and need…

laurabbook@gmail.comOctober 30, 2022

Advocacy Research Treatments

What is Meant by “Informed Consent”?

*August 2022* By EGFR Resisters Co-founder Ivy Elkins for Lungcancer.net Unless you have participated in a clinical trial, you might not be familiar with the term “informed consent,” commonly used to refer to the document that patients are given when they are considering signing up for a trial. This document…

laurabbook@gmail.comSeptember 24, 2022

Advocacy

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

*May 2022* EGFR Resisters co-founder Jill Feldman participated as a panelist in this FDA Oncology Workship: 3a "Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics; and 3b "Opportunities to Improve Dose Optimization: Assessing Safety and Tolerability." Current strategies for determining the recommended dose(s) of anticancer agents for evaluation…

laurabbook@gmail.comJuly 3, 2022

Jill Feldman - EGFR resisters group founder

Advocacy

I Don’t Want to Survive, I Want to Live

*April 2022* Video: Jill Feldman, co-founder of the EGFR Resisters and Stage 4 lung cancer survivor since 2009, speaks about survivorship at ELCC. Even care Watch video here.

laurabbook@gmail.comJune 29, 2022

Advocacy

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

*February 2022* EGFR Resisters Co-Founder Ivy Elkins gave a presentation on “Keeping Your Work Focused on Patients" at the IASLC 2022 Targeted Therapies of Lung Cancer Meeting. This presentation was part of a special Early Career Workshop aimed at young investigators and focused on critical topics of interest to them…

laurabbook@gmail.comMarch 23, 2022

Advocacy Research Treatments

Video: Who’s in? Who’s out? How Patients Are Selected for Clinical Trials

*January 2022* In this video, EGFR Resisters co-founder Jill Feldman discusses this topic with Dr. Jorge J Nieva of USC Norris Comprehensive Cancer Center.

laurabbook@gmail.comMarch 16, 2022

Advocacy Research Treatments

Video: Clinical Trial Life Cycle

*January 2022* In this video, EGFR Resisters co-founders Jill Feldman and Ivy Elkins gave a presentation about the clinical trial life cycle. It starts at about 1:50.

laurabbook@gmail.comMarch 16, 2022

Passing of The Baton—On the Death of Patient Research Advocates

Video Summary Recap: 2022 EGFR Resisters Research Summit

Lung Cancer Research Foundation (LCRF) and EGFR Resisters Announce Research Awards

Epidemiology of Young Lung Cancer Study

What is Meant by “Informed Consent”?

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

I Don’t Want to Survive, I Want to Live

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

Video: Who’s in? Who’s out? How Patients Are Selected for Clinical Trials

Video: Clinical Trial Life Cycle

GIVE TODAY

Categories

STAY CONNECTED

You Might Like

BECOME A MEMBER

QUICK LINKS

WHO WE ARE

PROJECTS

ALLIANCES & RESOURCES